Megan Orlando

Megan Orlando has over a decade of experience in financial leadership and cost accounting, currently serving as Director of Gross to Net Planning and Analysis at Teva Pharmaceuticals since October 2012. In this role, Megan has also held positions including Director of US Commercial Cost Accounting and Associate Director of Accounting, focusing on cost accounting efforts. Prior to Teva, Megan spent over four years at Gamesa Technology Corporation in various cost accounting roles, including Senior Accountant for multiple entities. Earlier experience includes a consultancy role at IBM Global Services, working on projects for the Federal Highway Administration. Megan holds a Bachelor of Science in Accounting from Penn State University, earned between 2003 and 2007.